Heron Therapeutics Enters into Loan Agreement for Up to $100 Million
08/02/2016
|
About
Forward-Looking Statements
This news release contains "forward-looking statements" as defined by
the Private Securities Litigation Reform Act of 1995. Heron cautions
readers that forward-looking statements are based on management’s
expectations and assumptions as of the date of this news release, and
involve substantial risks and uncertainties that could cause our future
results, performance or achievements to differ significantly from those
expressed or implied by the forward-looking statements. These risks and
uncertainties include, but are not limited to, those associated with:
the projected sufficiency of our capital position for future periods,
our ability to repay any indebtedness, and other risks and uncertainties
identified in the Company's filings with the
View source version on businesswire.com: http://www.businesswire.com/news/home/20160802005552/en/
Source:
Investor Relations and Media Contact:
Heron Therapeutics,
Inc.
Jennifer Capuzelo, 858-703-6063
Associate Director,
Investor Relations
jcapuzelo@herontx.com